Francisco Chacón-Lozsán/LinkedIn
Mar 22, 2026, 14:46
Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine (ESICM) and American College of Cardiology, shared on LinkedIn:
”’PE is the new STEMI’ — but are we treating it too aggressively?
One of the most thought-provoking sessions at ACVC26 challenged the growing enthusiasm for catheter-directed therapies.
The message was clear:
- Not every PE needs intervention
- In fact, most patients do well with anticoagulation alone
- The real challenge is not how to treat – but who to treat.
Current risk scores don’t capture the full picture
More evidence is underway.
We need to move toward:
- Better understanding of RV failure
- Early identification of decompensation
- Truly individualized decision-making
Until then: Avoid ‘wild’ use of catheter-based therapies”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom